This message contains images. If you don't see images, click here to view.
Advertise in this news brief.




Text Version   RSS   Subscribe   Unsubscribe   Archive   Media Kit April 16, 2014


 

Advertisement

Breast cancer treatment: A better way to check the lymph nodes
Consumer Health Choices
Lymph nodes are small glands in the underarms and many other places in the body. If you have breast cancer, your doctor will usually check the underarm lymph nodes. Most breast cancer is invasive. This means that it can spread. The doctor checks the lymph nodes in the underarm to find out if the cancer has spread and to plan what treatment is needed after surgery.
   Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE  


Less invasive technique possible for vulvar cancer
Oncology Nurse Advisor
Sentinel lymph node dissection in women with vulvar malignancies allowed gynecologic oncology surgeons to identify and remove just the sentinel nodes and follow the patients for complications and recurrence, according to new research. The study was presented at the main plenary session of the annual meeting of the Society of Gynecologic Oncologists in Tampa, Fla. Using radioactive dye and blue dye, gynecologic oncology surgeons are able to identify and remove just the sentinel nodes, which is the first place the cancer will go.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Version 3 of the CP³R now available
ACS
The latest version of the Cancer Program Practice Profile Reports (CP³R) has been posted with the following features:
  • Data are displayed for diagnosis years 2009, 2010, and 2011.
  • Three new breast measures have been added (see more information at http://www.facs.org/cancer/qualitymeasures.html).
  • Registrars can edit codes that affect whether or not the case belongs in the denominator of the measures, replacing the function of the former "censor" button.
  • Navigation is simplified, and both facility and comparison performance rates update when changes are made.
  • Documentation is improved (see http://www.facs.org/cancer/ncdb/cp3r.html).

Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Advertisement
PRODUCT SHOWCASE
  The Top 10 Metrics to Maximize Your Practice's Revenue

MediGain has analyzed the top physicians offices around the country and compiled the Top 10 Metrics they use to maximize their practice's revenue. You can't manage what you can't measure. Here are 10 metrics that you can track so you can spend more time providing quality health care for your patients. Plus, you will end up with more cash at the end of the day/month/year.
 


CAP awarded more than $1.25 million in CDC grants
The College of American Pathologists
The College of American Pathologists (CAP), the world’s largest organization of board-certified pathologists, has been awarded two grants from the Centers for Disease Control and Prevention (CDC). The funding, totaling more than $1.25 million, will be used to improve the adoption of evidence-based laboratory testing guidelines and to standardize reporting of biomarker test results to cancer registries. The grant dollars will be used over a five-year period.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Register now for the 2014 CoC workshop — Strengthening Your Cancer Program...Enriching the Coordinators' Role
Commission on Cancer
On June 19-20 in Chicago, the Commission on Cancer (CoC) will hold a new workshop entitled Strengthening Your Cancer Program…Enriching the Coordinators' Role. This program provides information and case studies on the roles and responsibilities of the various CoC-designated coordinators. The two-day program will cover what the various coordinators' roles are, what their roles on the cancer committee involve, and how to meet and improve the required responsibilities based on the CoC Standards. Register for the program. Program fees are $650 if registration is received on or before May 15 and $750 if registration is received after May 15.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article


Immunotherapy data marks new era for treating lung cancer
Oncology Nurse Advisor
A new era of lung cancer therapy is close to dawning, using drugs that can prevent tumor cells from evading the immune system, experts said at the Fourth European Lung Cancer Congress (ELCC) in Geneva, Switzerland. For decades, scientists and doctors thought immunotherapy, which uses treatments that harness the immune system to fight a disease, was of marginal benefit in lung cancer, said Jean-Charles Soria, MD, PhD, Institute Gustave Roussy in Paris, France.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Study links coffee to lower liver cancer risk
HealthDay News via WebMD
Researchers say they've discovered yet another reason to love coffee: A new study suggests that people who drink at least a cup a day have a lower risk of liver cancer compared to those who only indulge occasionally. When the study started in the 1990s, researchers asked nearly 180,000 adults of different racial and ethnic backgrounds about their coffee drinking and other lifestyle habits. Study participants have now been tracked for as long as 18 years, and researchers have kept tabs on how many have developed hepatocellular carcinoma, the most common kind of liver cancer. So far, 498 study participants have been diagnosed.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Register now — Strengthening Your Cancer Program...Utilizing the Rapid Quality Reporting System to Comply with the New Commendation Standard
Commission on Cancer
Strengthening Your Cancer Program...Utilizing the Rapid Quality Reporting System to Comply with the New Commendation Standard will be held on June 18 in Chicago, the day before the 2014 CoC Workshop. This workshop will provide important information to help your program comply with the new commendation standard that requires programs, from initial enrollment and throughout the three-year accreditation period, to participate in the Rapid Quality Reporting System (RQRS). Register now for the program; registration fees are $250 if registration is received on or before May 15 and $300 if registration is received after May 15, 2014.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article


Chemotherapy superior to TKIs in advanced, EGFR wild-type NSCLC
HemOnc Today
Patients with advanced, EGFR wild-type non–small-cell lung cancer with wild-type EGFR demonstrated improved PFS when treated with conventional chemotherapy compared with EGFR tyrosine kinase inhibitors, according to results of a meta-analysis. However, researchers observed no OS benefit. Researchers evaluated 11 randomized controlled trials identified with the PubMed, EMBASE and Cochrane databases, and from ASCO and European Society for Medical Oncology meeting abstracts.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Blocking DNA repair mechanisms could improve radiation therapy for deadly brain cancer
Science Codex
Radiation therapy causes double-strand breaks in DNA that must be repaired for tumors to keep growing. Scientists have long theorized that if they could find a way to block repairs from being made, they could prevent tumors from growing or at least slow down the growth, thereby extending patients' survival. Blocking DNA repair is a particularly attractive strategy for treating glioblastomas, as these tumors are highly resistant to radiation therapy. In a study, UT Southwestern researchers demonstrated that the theory actually works in the context of glioblastomas.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


The Recovery Room Show — New episode available
ACS
You understand health, but do you understand medicine? Making sense of modern medicine, The Recovery Room, supported by the American College of Surgeons and hosted by Frederick L. Greene, MD, FACS, is an audio conversation with experts in surgery, medicine, ethics, and public health about the latest developments in medicine and health care. The latest episode, "Smoking Cessation and the Surgical Patient," is now available. It features Eric Skipper, MD, FACS, chief of adult cardiothoracic surgery at the Sanger Heart & Vascular Institute, Charlotte, N.C., and Michael Rosen, MD, FACS, professor of surgery and chief of GI and general surgery at Case Western Reserve University, Cleveland, Ohio.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Breast cancer in young women
Centers for Disease Control and Prevention
Most breast cancers are found in women who are 50 years old or older, but breast cancer also affects younger women. About 11 percent of all new cases of breast cancer in the United States are found in women younger than 45 years of age. Several different factors can affect cancer risk, so what can women under 45 do to reduce their risk?
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


National Accreditation Program for Breast Centers presents the Pursuing Excellence through Accreditation Workshop
NAPBC
Plan now to attend the Pursuing Excellence through Accreditation Workshop May 23 in Chicago. Designed for centers seeking accreditation for the first time as well as centers due for re-accreditation, this program will increase your understanding of the National Accreditation Program for Breast Centers (NAPBC) accreditation process and help you prepare for the survey visit. Space is limited, so please make sure you register early.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE
 
Advertisement

Advertisement



The CoC Brief

Colby Horton, Vice President of Publishing, 469.420.2601
Download media kit

Samantha Emerson, Content Editor, 469.420.2669
Contribute news

Disclaimer: The CoC Brief is a digest of the most important news selected for the American College of Surgeons Commission on Cancer from thousands of sources by the editors of MultiBriefs, an independent organization that also manages and sells advertising. The Commission on Cancer does not endorse any of the advertised products and services. Opinions expressed in the articles are those of the author and not of the American College of Surgeons and the Commission on Cancer.


Be sure to add us to your address book or safe sender list so our emails get to your inbox. Learn how.

This edition of The CoC Brief was sent to ##Email##. To unsubscribe, click here. Did someone forward this edition to you? Subscribe here — it's free!

Recent issues

April 9, 2014
April 2, 2014
March 26, 2014
March 19, 2014






7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063